Abstract | OBJECTIVES: METHODS: Patients with MPE, performance status of 0-1, possibility of good lung expansion and Cr<1.2mg/dL were treated with IPHC. The circuit was filled with 2000mL of normal saline containing cisplatin at a dose of 80mg/m2. Under video-assisted thoracoscopic surgery, the thoracic cavity was filled and perfused at a speed of approximately 1L/min at a temperature of 43°C for 1h. Perfusion solution and plasma samples were periodically collected, and concentrations of protein-unbound (free) platinum, which was the active derivative of cisplatin, and total platinum were determined by flameless atomic absorption spectrometry. RESULTS: Twenty patients with MPE (8 lung cancers, 7 mesotheliomas, and 5 others) were enrolled in this study. Rate of free platinum concentration relative to total platinum concentration in perfusion solution after 1hr IPHC at 43°C was 61.1±12.9%. Area under curve (AUC) of free platinum in the pleural space was calculated to be 26.3μg/mLxh, resulting in complete control of pleural effusion for 3 months after IHPC in all cases (95% confidence interval: 83-100%). While, absorption rate of total platinum from the pleural space was 33.8±17.0% (27.4±13.6mg/m2), and the maximum concentration of total platinum in serum was low, 0.66±0.31μg/mL, resulting in controllable side effects; grade 1 renal toxicity: 6 patients, grade 1 emesis: 7 patients. CONCLUSIONS:
|
Authors | Hirozo Sakaguchi, H Ishida, H Nitanda, N Yamazaki, K Kaneko, Kunihiko Kobayashi |
Journal | Lung cancer (Amsterdam, Netherlands)
(Lung Cancer)
Vol. 104
Pg. 70-74
(02 2017)
ISSN: 1872-8332 [Electronic] Ireland |
PMID | 28213004
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2016 The Author(s). Published by Elsevier B.V. All rights reserved. |
Chemical References |
|
Topics |
- Adult
- Aged
- Cisplatin
(administration & dosage, adverse effects, pharmacokinetics, pharmacology)
- Female
- Humans
- Hyperthermia, Induced
(adverse effects, methods)
- Infusions, Intralesional
(adverse effects, instrumentation)
- Lung Neoplasms
(complications, drug therapy, pathology, surgery)
- Male
- Mesothelioma
(drug therapy)
- Middle Aged
- Perfusion
(adverse effects, methods)
- Platinum
(therapeutic use)
- Pleural Cavity
(drug effects)
- Pleural Effusion, Malignant
(drug therapy, pathology)
- Pleural Neoplasms
(drug therapy)
- Prospective Studies
- Thoracic Surgery, Video-Assisted
(methods)
|